CoChat
Cited by 1,376

The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.

Challenges of Antibacterial Discovery

Open access
Silver, Lynn L. · 2011 · Clinical Microbiology Reviews

Abstract

SUMMARY: The discovery of novel small-molecule antibacterial drugs has been stalled for many years. The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort. The major challenges fall into two areas: (i) proper target selection, particularly the necessity of pursuing molecular targets that are not prone to rapid resistance development, and (ii) improvement of chemical libraries to overcome limitations of diversity, especially that which is necessary to overcome barriers to bacterial entry and proclivity to be effluxed, especially in Gram-negative organisms. Failure to address these problems has led to a great deal of misdirected effort.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.00030-10

Cites

287 of 287 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–287 of 287

Research works printed but not linked: 114

  1. 10.1016/S1044-0305(96)00104-3 · doi:10.1016/s1044-0305(96)00104-3
  2. 10.1016/j.bmcl.2007.02.056 · doi:10.1016/j.bmcl.2007.02.056
  3. 10.1021/jm020483c · doi:10.1021/jm020483c
  4. 10.1016/S0960-894X(00)00073-1 · doi:10.1016/s0960-894x(00)00073-1
  5. 10.1016/j.bmcl.2005.09.021 · doi:10.1016/j.bmcl.2005.09.021
  6. 10.1128/AAC.45.4.1058-1064.2001 · doi:10.1128/aac.45.4.1058-1064.2001
  7. 10.1155/2010/315056 · doi:10.1155/2010/315056
  8. Baltz, R. H. 2005. Antibiotic discovery from Actinomycetes: will a renaissance follow the decline and fall. SIM News 55 : 186-196.
  9. 10.1021/bi900167q · doi:10.1021/bi900167q
  10. 10.1021/bi6025165 · doi:10.1021/bi6025165
  11. 10.1128/AAC.46.4.943-946.2002 · DOI
  12. 10.1128/AAC.50.1.230-236.2006 · doi:10.1128/aac.50.1.230-236.2006
  13. 10.1128/AAC.00845-07 · doi:10.1128/aac.00845-07
  14. 10.1111/j.1574-6968.1988.tb13933.x · doi:10.1111/j.1574-6968.1988.tb13933.x
  15. 10.1016/0006-291X(86)90452-3 · doi:10.1016/0006-291x(86)90452-3
  16. 10.1021/bi050767 · doi:10.1021/bi050767
  17. 10.1016/j.coph.2008.04.009 · doi:10.1016/j.coph.2008.04.009
  18. 10.2174/092986707780831168 · doi:10.2174/092986707780831168
  19. 10.1016/S0960-894X(02)01076-4 · doi:10.1016/s0960-894x(02)01076-4
  20. Brown D. W. 2010. The evolution of a fosfomycin resistance enzyme FosA from P. aeruginosa and the development of a high throughput screen for the discovery of bioactive inhibitors. Ph.D. thesis. Vanderbilt University Nashville TN.
  21. 10.1128/jb.171.7.4071-4072.1989 · doi:10.1128/jb.171.7.4071-4072.1989
  22. 10.1021/jm800318d · doi:10.1021/jm800318d
  23. 10.2174/187152109787047805 · doi:10.2174/187152109787047805
  24. 10.1006/jmbi.1996.0274 · doi:10.1006/jmbi.1996.0274
  25. 10.1128/AAC.48.1.250-261.2004 · doi:10.1128/aac.48.1.250-261.2004
  26. Chopra, I. 2000. New drugs for the superbugs. Microbiol. Today 27 : 4-6.
  27. 10.1021/jm00010a027 · doi:10.1021/jm00010a027
  28. 10.1517/13543770902766829 · doi:10.1517/13543770902766829
  29. 10.7164/antibiotics.40.761 · doi:10.7164/antibiotics.40.761
  30. 10.1021/jm020901d · doi:10.1021/jm020901d
  31. Drlica, K. 2001. A strategy for fighting antibiotic resistance. ASM News 67 : 27-33.
  32. 10.1086/499046 · DOI
  33. 10.1016/j.bmcl.2008.11.102 · doi:10.1016/j.bmcl.2008.11.102
  34. 10.1016/j.bbapap.2003.11.006 · doi:10.1016/j.bbapap.2003.11.006
  35. Elespuru, R. K., and R. J. White. 1983. Biochemical prophage induction assay: a rapid test for antitumor agents that interact with DNA. Cancer Res. 43 : 2819-2830.
  36. 10.1074/jbc.M414412200 · doi:10.1074/jbc.m414412200
  37. 10.1128/AAC.49.9.3715-3723.2005 · doi:10.1128/aac.49.9.3715-3723.2005
  38. Evdokimov, A., M. Pokross, R. L. Walter, M. Mekel, B. L. Barnett, J. Amburgey, W. L. Seibel, S. J. Soper, J. F. Djung, N. Fairweather, C. Diven, V. Rastogi, L. Grinius, C. Klanke, R. Siehnel, T. Twinem, R. Andrews, and A. Curnow. 2007. Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors. Proteins 66 : 538-546. · doi:10.1002/prot.21207
  39. 10.1128/AAC.50.4.1136-1142.2006 · doi:10.1128/aac.50.4.1136-1142.2006
  40. 10.1016/S0960-894X(98)00285-6 · doi:10.1016/s0960-894x(98)00285-6
  41. 10.1016/j.bmcl.2008.11.113 · doi:10.1016/j.bmcl.2008.11.113
  42. 10.1128/jb.88.4.1112-1118.1964 · doi:10.1128/jb.88.4.1112-1118.1964
  43. 10.1128/AAC.00275-08 · doi:10.1128/aac.00275-08
  44. 10.1128/AAC.00596-06 · doi:10.1128/aac.00596-06
  45. 10.1128/AAC.50.1.401-402.2006 · doi:10.1128/aac.50.1.401-402.2006
  46. Guay, D. R. 2007. Drug forecast—the peptide deformylase inhibitors as antibacterial agents. Ther. Clin. Risk Manage. 3 : 513-525.
  47. 10.1128/AAC.49.8.3178-3181.2005 · doi:10.1128/aac.49.8.3178-3181.2005
  48. 10.1007/BF01709702 · doi:10.1007/bf01709702
  49. 10.1128/AAC.22.4.662 · doi:10.1128/aac.22.4.662
  50. 10.1021/jm050920y · doi:10.1021/jm050920y
  51. 10.1128/AAC.01321-06 · doi:10.1128/aac.01321-06
  52. 10.1016/S0968-0896(03)00083-X · doi:10.1016/s0968-0896(03)00083-x
  53. 10.1128/AAC.49.1.131-136.2005 · doi:10.1128/aac.49.1.131-136.2005
  54. 10.1128/AAC.01254-06 · doi:10.1128/aac.01254-06
  55. 10.1038/nbt1206-1529 · doi:10.1038/nbt1206-1529
  56. 10.1001/archinte.1956.00250250007001 · doi:10.1001/archinte.1956.00250250007001
  57. Kitamoto, O., N. Kasai, K. Fukuya, and A. Kawashima. 1956. Drug sensitivity of the Shigella strains isolated in 1955. J. Jpn. Assoc. Infect. Dis. 30 : 403-404.
  58. 10.1128/AAC.40.8.1768 · doi:10.1128/aac.40.8.1768
  59. 10.2174/138161207781368828 · doi:10.2174/138161207781368828
  60. 10.1128/AAC.49.3.987-995.2005 · DOI
  61. 10.1016/j.bmcl.2005.03.058 · DOI
  62. 10.1248/bpb.32.2061 · doi:10.1248/bpb.32.2061
  63. 10.1021/bi100523c · doi:10.1021/bi100523c
  64. Leeds, J. A., and C. R. Dean. 2006. Peptide deformylase as an antibacterial target: a critical assessment. Curr. Opin. Pharmacol. 8 : 8.
  65. 10.1128/AAC.00073-07 · doi:10.1128/aac.00073-07
  66. 10.1007/BF00341730 · doi:10.1007/bf00341730
  67. 10.1128/jb.109.1.326-335.1972 · doi:10.1128/jb.109.1.326-335.1972
  68. 10.1128/jb.110.1.35-40.1972 · doi:10.1128/jb.110.1.35-40.1972
  69. 10.1128/jb.110.1.41-46.1972 · doi:10.1128/jb.110.1.41-46.1972
  70. 10.1128/jb.113.1.96-104.1973 · doi:10.1128/jb.113.1.96-104.1973
  71. 10.1128/AAC.50.4.1228-1237.2006 · doi:10.1128/aac.50.4.1228-1237.2006
  72. 10.1128/AAC.42.11.2836 · doi:10.1128/aac.42.11.2836
  73. 10.1128/AAC.18.2.215 · doi:10.1128/aac.18.2.215
  74. Miller, D. J., S. M. Hammond, D. Anderluzzi, and T. D. Bugg. 1998. Aminoalkylphosphinate inhibitors of d-Ala-d-Ala adding enzyme. J. Chem. Soc. Perkin 1 1 : 131-142.
  75. Miller, M. 1995. Aminoglycoside transport, p. 175-219. In N. Georgopapdakou (ed.), Drug transport in antimicrobial and anticancer chemotherapy. Marcel Dekker, Inc., New York, NY.
  76. 10.1021/jm020050 · doi:10.1021/jm020050
  77. 10.1016/j.bmcl.2004.01.014 · doi:10.1016/j.bmcl.2004.01.014
  78. 10.1093/jac/dkn261 · doi:10.1093/jac/dkn261
  79. 10.1016/j.exppara.2007.06.008 · doi:10.1016/j.exppara.2007.06.008
  80. 10.2174/092986707781368414 · doi:10.2174/092986707781368414
  81. Oiwa, R. 1992. Antibacterial agents, p. 1-29. In S. Omura (ed.), The search for bioactive compounds from microorganisms. Springer-Verlag, New York, NY.
  82. 10.1128/AAC.45.1.1599-1600.2001 · doi:10.1128/aac.45.1.1599-1600.2001
  83. 10.1534/genetics.109.113514 · doi:10.1534/genetics.109.113514
  84. 10.1016/j.bmcl.2008.02.009 · doi:10.1016/j.bmcl.2008.02.009
  85. 10.1016/j.bmcl.2008.10.040 · doi:10.1016/j.bmcl.2008.10.040
  86. 10.1111/j.1465-0691.2004.1006.x · doi:10.1111/j.1465-0691.2004.1006.x
  87. 10.1128/AAC.48.12.4835-4842.2004 · DOI
  88. 10.1016/S0960-894X(01)00251-7 · doi:10.1016/s0960-894x(01)00251-7
  89. 10.1517/17425250902988487 · doi:10.1517/17425250902988487
  90. Ryder, N. S. 2009. Discontinued drugs in 2008: anti-infectives. Expert Opin. Invest. Drugs 19 : 1-21.
  91. 10.1093/oxfordjournals.jbchem.a130606 · doi:10.1093/oxfordjournals.jbchem.a130606
  92. 10.1159/000472864 · doi:10.1159/000472864
  93. 10.7164/antibiotics.50.22 · doi:10.7164/antibiotics.50.22
  94. 10.1517/14728220903005590 · doi:10.1517/14728220903005590
  95. Silver, L. L. 2005. A retrospective on the failures and successes of antibacterial drug discovery. IDrugs 8 : 651-655.
  96. 10.1016/j.bcp.2005.10.029 · doi:10.1016/j.bcp.2005.10.029
  97. Skipper, H. E., J. R. Thomson, and M. Bell. 1954. Attempts at dual blocking of biochemical events in cancer chemotherapy. Cancer Res. 14 : 503-507.
  98. 10.1111/j.1464-410X.1963.tb02604.x · doi:10.1111/j.1464-410x.1963.tb02604.x
  99. 10.1128/jb.132.1.73-79.1977 · doi:10.1128/jb.132.1.73-79.1977
  100. 10.1111/j.1747-0285.2005.00317.x · doi:10.1111/j.1747-0285.2005.00317.x
  101. 10.1128/am.6.6.392-398.1958 · doi:10.1128/am.6.6.392-398.1958
  102. 10.1016/j.bmcl.2009.07.141 · doi:10.1016/j.bmcl.2009.07.141
  103. 10.1021/jm030394f · doi:10.1021/jm030394f
  104. 10.1016/j.bmcl.2005.06.103 · doi:10.1016/j.bmcl.2005.06.103
  105. 10.1021/jo951780a · doi:10.1021/jo951780a
  106. Tomasic, T., N. Zidar, A. Kovac, S. Turk, M. Simcic, D. Blanot, M. Müller-Premru, M. Filipic, S. Golic Grdadolnik, A. Zega, M. Anderluh, S. Gobec, D. Kikelj, and L. P. Masic. 2009. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. ChemMedChem 5 : 286-295.
  107. 10.1054/drup.1999.0111 · doi:10.1054/drup.1999.0111
  108. Tung, R. D. 2002. Design and synthesis of amprenavir, a novel HIV protease inhibitor. Infect. Dis. Ther. 25 : 101-118.
  109. 10.1016/j.bmc.2009.01.052 · doi:10.1016/j.bmc.2009.01.052
  110. 10.1111/j.1365-2885.1994.tb00251.x · DOI
  111. 10.7164/antibiotics.56.1045 · doi:10.7164/antibiotics.56.1045
  112. 10.1016/j.bmcl.2007.03.004 · doi:10.1016/j.bmcl.2007.03.004
  113. Woodruff, H. B., J. M. Mata, S. Hernàndez, S. Mochales, A. Rodríguez, E. O. Stapley, H. Wallick, A. K. Miller, and D. Hendlin. 1977. Fosfomycin: laboratory studies. Chemotherapy 23 : 1-22.
  114. 10.1111/j.1749-6632.1974.tb43292.x · doi:10.1111/j.1749-6632.1974.tb43292.x

Cited by

See all 1,376

Metadata

Authors
Silver, L. L.
Venue
Clinical Microbiology Reviews
Published
2011-01
Volume
24
Issue
1
Pages
71-109
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
OpenAlex
W2139516496
Cited by
1,376
References
287
FWCI
27.74
Type
journal article
Language
en
Open access
green
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.